Weihong Ding
Impact in
-
- Cancer, Lipids, and Metabolism
-
- Peptidase Inhibition and Analysis
- Inflammatory Biomarkers in Disease Prognosis
Papers in
- Surgery 11
- Bladder and Urothelial Cancer Treatments 10
- Urinary and Genital Oncology Studies 6
-
- Prostate Cancer Treatment and Research 8
- Co-authors
- Ke Xu (17 shared papers)Guowei Xia (14 shared papers)Chuanyu Sun (14 shared papers)Yuancheng Gou (9 shared papers)Qiang Ding (12 shared papers)Yuan Gao (4 shared papers)Shijun Tong (6 shared papers)Qingfeng Hu (4 shared papers)
- Journals
- British Journal of Pharmacology (2 papers)Urologic Oncology Seminars and Original Investigations (2 papers)Bioscience Reports (1 paper)Molecular Pharmaceutics (1 paper)iScience (1 paper)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Weihong Ding
26 papers receiving 623 citations
Peers
Comparison fields: 5 of 77
- Cancer Research 146
- Oncology 211
- Biological Psychiatry 16
- Pulmonary and Respiratory Medicine 201
- Molecular Biology 266
Countries citing papers authored by Weihong Ding
This map shows the geographic impact of Weihong Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weihong Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weihong Ding more than expected).
Fields of papers citing papers by Weihong Ding
This network shows the impact of papers produced by Weihong Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weihong Ding. The network helps show where Weihong Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Weihong Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 73 | |
| 2 | 2015 | 69 | |
| 3 | 2013 | 68 | |
| 4 | 2020 | 56 | |
| 5 | 2013 | 45 | |
| 6 | 2021 | 37 | |
| 7 | 2012 | 33 | |
| 8 | 2011 | 33 | |
| 9 | 2011 | 33 | |
| 10 | 2016 | 29 | |
| 11 | 2015 | 23 | |
| 12 | 2017 | 18 | |
| 13 | 2023 | 14 | |
| 14 | 2021 | 12 | |
| 15 | 2014 | 12 | |
| 16 | 2014 | 12 | |
| 17 | 2020 | 11 | |
| 18 | 2018 | 10 | |
| 19 | 2021 | 9 | |
| 20 | 2021 | 9 |
About Weihong Ding
Weihong Ding is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Immunology, having authored 27 papers that have together received 629 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (10 papers), Prostate Cancer Treatment and Research (8 papers), Urinary and Genital Oncology Studies (6 papers), Immune cells in cancer (4 papers), Cancer, Lipids, and Metabolism (3 papers), Cancer, Stress, Anesthesia, and Immune Response (3 papers), Cardiac Fibrosis and Remodeling (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Cancer Research (146 citations), Oncology (211 citations), Biological Psychiatry (16 citations), Pulmonary and Respiratory Medicine (201 citations) and Molecular Biology (266 citations). Weihong Ding has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Ke Xu, Guowei Xia, Chuanyu Sun, Yuancheng Gou, Qiang Ding, Yuan Gao, Shijun Tong, Qingfeng Hu, Shen Gao and Zhongqing Chen. Their work appears in journals such as British Journal of Pharmacology, Urologic Oncology Seminars and Original Investigations, Bioscience Reports, Molecular Pharmaceutics and iScience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.